{"name":"Nicoletta C Machin","slug":"nicoletta-c-machin","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Hematology","slug":"hematology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"IV Iron (standard of care)","genericName":"IV Iron (standard of care)","slug":"iv-iron-standard-of-care","indication":"Iron deficiency anemia in patients intolerant of or unresponsive to oral iron","status":"phase_3"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Recombinant Von Willebrand factor","genericName":"Recombinant Von Willebrand factor","slug":"recombinant-von-willebrand-factor","indication":"Von Willebrand disease (Type 1, 2, and 3)","status":"marketed"}]}],"pipeline":[{"name":"IV Iron (standard of care)","genericName":"IV Iron (standard of care)","slug":"iv-iron-standard-of-care","phase":"phase_3","mechanism":"IV iron replenishes depleted iron stores by delivering iron directly into the bloodstream for incorporation into hemoglobin and other iron-dependent proteins.","indications":["Iron deficiency anemia in patients intolerant of or unresponsive to oral iron","Iron deficiency anemia in chronic kidney disease patients on hemodialysis","Perioperative iron replacement"],"catalyst":""},{"name":"Recombinant Von Willebrand factor","genericName":"Recombinant Von Willebrand factor","slug":"recombinant-von-willebrand-factor","phase":"marketed","mechanism":"Recombinant von Willebrand factor replaces or supplements the natural von Willebrand factor protein to restore platelet adhesion and coagulation factor VIII binding.","indications":["Von Willebrand disease (Type 1, 2, and 3)","Factor VIII deficiency associated with von Willebrand disease"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":2,"phaseCounts":{"phase_3":1,"marketed":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}